NPR3 and pulmonary arterial hypertension: As activation of NPR-C signaling may have anti-proliferative effects, hypoxia-induced down regulation of NPR-C expression and associated impaired NPR-C pathways may lead to failure of the NPRC-related antiproliferative effects in the pulmonary vasculature, which may then ultimately lead to PAH [1].